11 May - 13 May 2021

PEGS BOSTON VIRTUAL SUMMIT

Together we made it again - the #PEGS21 was a success! We're grateful for the well-organized PEGS Boston Summit 2021 and extend our thank you to the PEGS Boston organizing committee, speakers, poster presenters, delegates as well as other sponsors and exhibitors.

Our scientific contributions at PEGS, are now available for you!

11 May - 13 May 2021

PEGS BOSTON VIRTUAL SUMMIT

Together we made it again - the #PEGS21 was a success! We're grateful for the well-organized PEGS Boston Summit 2021 and extend our thank you to the PEGS Boston organizing committee, speakers, poster presenters, delegates as well as other sponsors and exhibitors.

Our scientific contributions at PEGS, are now available for you!

🔸 POSTER PRESENTATION

"Characterization of a Reporter Gene Cell Line for the Easy Assessment of Therapeutic AAV Vectors – A Case Study"

Poster written by Jordi Rodó - Research Scientist, Karin Blume - Taam Lead &  Senior Scientist, and Therese Segerstein - Product Manager. 

Learn more about the development of a reporter gene assay technology, that allows assessment and quantification of presence, activity, and function of a therapeutic AAV vector. 

Learn more

🔸 SCIENTIFIC TALK 

"Quantification of the Neutralizing Antibody Response to Recombinant AAV Vectors  - Highly sensitive iLite® reporter assay, providing a highly sensitive, rapid, precise method for quantifying NAb response to a wide range of recombinant AAV vectors.”

Speaker: Michael G. Tovey, Ph.D. - Chief Scientific Advisor of Svar Life Science, France. (Track: Immunogenicity Assessment and Management)

Learn about an assay based on a packaging cell line expressing a recombinant virus, containing a tag sequence within the ITRs and a serotype-specific cap gene recognized specifically by a reporter cell line stably transfected with a luciferase reporter-gene placed under the control of an AAV-responsive chimeric promoter.

Learn more

🔸 ASK THE EXPERT

Svar's Expert session, hosted by Michael G. Tovey, Ph.D. - Chief Scientific Advisor of Svar Life Science, was focused on AAV mediated gene therapy and potential neutralizing antibody response to AAV vectors.

If you were not able to join the session during the event you are welcome to contact us to learn more about how Svars' highly sensitive reporter-gene assays are used for the quantification of NAbs to recombinant AAV vectors with different capsid specificities and find out how they can assist in your project.